Wells Fargo’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-37,033
| Closed | -$338K | – | 7350 |
|
|
2025
Q2 | $338K | Buy |
37,033
+2,991
| +9% | +$22K | ﹤0.01% | 4421 |
|
|
2025
Q1 | $271K | Buy |
34,042
+991
| +3% | +$7.26K | ﹤0.01% | 4489 |
|
|
2024
Q4 | $179K | Buy |
33,051
+7,087
| +27% | +$43.3K | ﹤0.01% | 4859 |
|
|
2024
Q3 | $187K | Buy |
25,964
+1,262
| +5% | +$11.6K | ﹤0.01% | 4625 |
|
|
2024
Q2 | $268K | Buy |
24,702
+7,380
| +43% | +$94.6K | ﹤0.01% | 4316 |
|
|
2024
Q1 | $325K | Buy |
17,322
+1,420
| +9% | +$32.8K | ﹤0.01% | 4174 |
|
|
2023
Q4 | $345K | Sell |
15,902
-72,207
| -82% | -$1.43M | ﹤0.01% | 4123 |
|
|
2023
Q3 | $1.81M | Buy |
88,109
+33,680
| +62% | +$973K | ﹤0.01% | 2876 |
|
|
2023
Q2 | $2.56M | Buy |
54,429
+3,194
| +6% | +$159K | ﹤0.01% | 2703 |
|
|
2023
Q1 | $2.15M | Buy |
51,235
+41,512
| +427% | +$1.78M | ﹤0.01% | 2801 |
|
|
2022
Q4 | $371K | Sell |
9,723
-2,664
| -22% | -$102K | ﹤0.01% | 3828 |
|
|
2022
Q3 | $485K | Buy |
12,387
+9,815
| +382% | +$379K | ﹤0.01% | 3700 |
|
|
2022
Q2 | $83K | Buy |
2,572
+1,020
| +66% | +$34.2K | ﹤0.01% | 4750 |
|
|
2022
Q1 | $52K | Buy |
1,552
+306
| +25% | +$11.5K | ﹤0.01% | 5640 |
|
|
2021
Q4 | $53K | Sell |
1,246
-73,097
| -98% | -$3.06M | ﹤0.01% | 5946 |
|
|
2021
Q3 | $3.29M | Sell |
74,343
-49,993
| -40% | -$2.29M | ﹤0.01% | 3236 |
|
|
2021
Q2 | $7.06M | Buy |
124,336
+20,820
| +20% | +$1.47M | ﹤0.01% | 2534 |
|
|
2021
Q1 | $7.75M | Sell |
103,516
-2,241
| -2% | -$184K | ﹤0.01% | 2428 |
|
|
2020
Q4 | $9.15M | Sell |
105,757
-38,308
| -27% | -$2.82M | ﹤0.01% | 2156 |
|
|
2020
Q3 | $8.81M | Buy |
144,065
+14,589
| +11% | +$739K | ﹤0.01% | 1976 |
|
|
2020
Q2 | $5.38M | Buy |
129,476
+14,014
| +12% | +$509K | ﹤0.01% | 2398 |
|
|
2020
Q1 | $3.32M | Buy |
115,462
+37,012
| +47% | +$2.14M | ﹤0.01% | 2579 |
|
|
2019
Q4 | $5.66M | Sell |
78,450
-361,540
| -82% | -$44.5M | ﹤0.01% | 2449 |
|
|
2019
Q3 | $61.7M | Buy |
439,990
+47,830
| +12% | +$8M | 0.02% | 787 |
|
|
2019
Q2 | $71.8M | Buy |
392,160
+20,855
| +6% | +$3.56M | 0.02% | 745 |
|
|
2019
Q1 | $59.1M | Buy |
371,305
+60,204
| +19% | +$8.72M | 0.02% | 805 |
|
|
2018
Q4 | $29.8M | Sell |
311,101
-77,605
| -20% | -$8.88M | 0.01% | 1129 |
|
|
2018
Q3 | $54.9M | Buy |
388,706
+109,250
| +39% | +$16.9M | 0.02% | 886 |
|
|
2018
Q2 | $43.7M | Buy |
279,456
+112,762
| +68% | +$17.7M | 0.01% | 986 |
|
|
2018
Q1 | $26.8M | Buy |
166,694
+135,469
| +434% | +$23M | 0.01% | 1272 |
|
|
2017
Q4 | $5.14M | Sell |
31,225
-72,791
| -70% | -$7.06M | ﹤0.01% | 2561 |
|
|
2017
Q3 | $6.48M | Buy |
104,016
+29,293
| +39% | +$2.3M | ﹤0.01% | 2316 |
|
|
2017
Q2 | $5.95M | Buy |
74,723
+41,148
| +123% | +$2.97M | ﹤0.01% | 2310 |
|
|
2017
Q1 | $2.39M | Sell |
33,575
-3,889
| -10% | -$228K | ﹤0.01% | 3051 |
|
|
2016
Q4 | $1.91M | Buy |
37,464
+16,125
| +76% | +$760K | ﹤0.01% | 3195 |
|
|
2016
Q3 | $982K | Sell |
21,339
-5,927
| -22% | -$241K | ﹤0.01% | 3504 |
|
|
2016
Q2 | $822K | Buy |
27,266
+1,874
| +7% | +$62.5K | ﹤0.01% | 3609 |
|
|
2016
Q1 | $814K | Buy |
25,392
+588
| +2% | +$20.7K | ﹤0.01% | 3533 |
|
|
2015
Q4 | $1.45M | Buy |
24,804
+9,548
| +63% | +$473K | ﹤0.01% | 3231 |
|
|
2015
Q3 | $646K | Buy |
15,256
+1,079
| +8% | +$66.5K | ﹤0.01% | 3788 |
|
|
2015
Q2 | $1.03M | Buy |
14,177
+12,548
| +770% | +$807K | ﹤0.01% | 3569 |
|
|
2015
Q1 | $82K | Buy |
1,629
+1,362
| +510% | +$58.6K | ﹤0.01% | 4824 |
|
|
2014
Q4 | $10K | Buy |
+267
| New | +$9.95K | ﹤0.01% | 5635 |
|
Other funds holding SAGE
IA
HNB